drugset / Trial / NCT05288855
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of voclosporin compared to placebo in achieving renal response following 24 weeks of therapy in adolescent and pediatric subjects with active lupus nephritis (LN).
Timeline
- Start
- 2023-10-10
- Primary completion
- 2025-07-03
- Completion
- 2025-07-03
Outcome
Outcome not reported
Stopped: “DSMB recommendation”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voclosporin | Other / unclassified | 15.8 mg | — |
| Subject | Voclosporin | Other / unclassified | 23.7 mg | — |